Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Lactobacillus rhamnosus and Improved Gastrointestinal Symptoms

Research synthesisLow evidenceModerate effect3 studies · 3 beneficial · 0 neutral · 0 harmful

Across 3 studies, all reported beneficial effects on gastrointestinal symptoms, with effect sizes predominantly moderate (one small, two moderate). However, none of the studies reported statistically significant results. The evidence primarily comes from individuals with autism spectrum disorder (ASD) and a chronically ill oncological cohort, with no consistent dose or form identified.

  • Studied populations: individuals with autism spectrum disorder (ASD) and chronically ill oncological patients

Caveats: Evidence base is small (only 3 studies) — conclusions should be considered preliminary. Available evidence is overwhelmingly positive — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed). Many of the included studies did not reach statistical significance — effect may be smaller than the predominant direction suggests.

Generated Jul 12, 2026
3 of 3 papers
Back to top